Brevan Howard Capital Management’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-46,021	Closed	-$79.6K	–	1119
2024 Q2	$79.6K	Buy	46,021 +32,799	+248%	+$56.7K	﹤0.01%	933
2024 Q1	$31.6K	Sell	13,222 -60,340	-82%	-$144K	﹤0.01%	904
2023 Q4	$245K	Buy	73,562 +62,110	+542%	+$207K	﹤0.01%	757
2023 Q3	$42.8K	Buy	+11,452	New	+$42.8K	﹤0.01%	311